Both China and India have been increasingly active participants in global health governance, but their contributions thus far fall short of international expectations and also fail to offer a viable, sustainable alternative to the existing governance paradigm.

CFR Senior Fellow Thomas J. Bollyky discusses the rise of noncommunicable diseases in low- and middle-income countries, the United Nations' efforts to address this rapidly emerging health problem, and paths for collective action.

Interest and political will for universal health coverage is growing across the world. Through risk-pooling, medical care can be made accessible and affordable in poor and emerging-market countries.

As tobacco use proliferates in the developing world, an innovative incentive mechanism could supplement tobacco control efforts in low- and middle-income countries.

As tobacco reemerges as a contentious issue in trade policy, CFR Senior Fellow Thomas Bollyky argues that the Obama administration can better balance U.S. mandates on tobacco trade policy with its interests in promoting global health and U.S. standing abroad.

This Working Paper, sponsored by CFR's International Institutions and Global Governance program, examines the complicated landscape of global health governance, assesses the capabilities of existing institutions, and recommends more effective strategies for policy implementation.

This Working Paper, a contribution to the aids2031 project, focuses on the future of donor financing for HIV prevention and treatment programs and makes recommendations for what the donor community and national governments can do now to build a foundation that ensures steady, long-term funding for HIV/AIDS and alleviates the impact of future challenges.

Though the United States of America faces its toughest budgetary and economic challenges since the Great Depression, it cannot afford to eliminate, or even reduce, its foreign assistance spending. For clear reasons of political influence, national security, global stability, and humanitarian concern the United States must, at a minimum, stay the course in its commitments to global health and development, as well as basic humanitarian relief. In this report, Laurie A. Garrett makes recommendations for the future of foreign aid under a new presidential administration and Congress.

In this Center for Geoeconomic Studies Working Paper, Laurie A. Garrett addresses the mistakes in humanitarian food polices and maps out a better way forward.

Note: The following is a rapporteur's report from the May 7, 2007 Council General Meeting "Is Male Circumcision the Key to Stopping the AIDS Epidemic?"

CFR's Peter Navario says a new patent pool giving generic drugmakers access to branded drugs to help lower costs of HIV-AIDS treatments in developing countries is timely and necessary, but more still needs to be accomplished.

CFR Fellow Peter Navario discusses the leveling off of South Africa's AIDS epidemic and its ability to step up HIV/AIDS treatments in light of "flatlined" global health funding.

CFR's Laurie Garrett says a number of factors delayed the World Health Organization from declaring swine flu a global pandemic, including internal politics and concerns about flaws in the alert system.

Drew Thompson, director of China studies at the Nixon Center, examines Beijing's proposed overhaul of its health care system--and the political and economic consequences if it fails.

Stephen Flynn, a leading homeland security expert, says while the initial U.S. response to the swine flu outbreak has gone reasonably well, the country remains ill prepared for a severe epidemic.

Lee Wells of the Touch Foundation discusses his work on training health workers in Tanzania and how the United States can most efficiently use its global-health aid dollars.

Jordan Kassalow, former CFR fellow for global health policy, says the problem of untreated impaired vision in the developing world is “huge,” and if this simple probem cannot be addressed, it does not bode well for more complex health issues such as HIV/AIDS.